NSU HPD Catalog 2021-2022

College of Pharmacy—M.S. in Pharmaceutical Sciences 219 PHRE 5228—Principles of Pharmaceutical Analysis This course explores the fundamentals of pharmaceutical analysis. This includes the principles of pharmaceutical analysis techniques and their applications in the pharmaceutical research and development (both academic and industrial). It is crafted to provide students with a solid conceptual ground to understand how a particular analytical technique works, to enable students to critically evaluate instrumentation choices when needed, and to allow them to select the appropriate tools. (48-0-3) PHRE 5244—Fundamentals of Pharmacognosy This course provides an overview of medicinal drugs derived from plants and other natural sources. The major classes of medicinally active natural products, their origin (nomenclature+taxonomy), structure, biosynthesis, andmode of action will be covered. The naturally derived constituents and their therapeutic efficacy will be discussed. (48-0-3) PHRE 5391—The Nuclear Pharmacy Experience This course covers and explains what a nuclear pharmacy is and the responsibilities, activities, and knowledge required in order to function as a nuclear pharmacist. It places emphasis on radiopharmaceuticals (radioactive medication), their mechanisms of action, dose ranges, methods of compounding, and ultimate role in the diagnosis and treatment of diseases. (32-0-2) PHRE 5412—Current Topics in Pharmacy Practice Topics on current issues, procedures, and policies related to pharmacy practice are discussed. Topics can vary from semester to semester. (48-0-3) PHRE 5432—Oncologic Treatments and Pharmacogenomics This hybrid course introduces the basic molecular concepts of cancer and pharmacogenomics in the context of cancer treatment. It presents the current methodologies used in cutting-edge oncology for the treatment of two of the most common types of cancer: breast and colon. The standard-ofcare combinatorial regimens will be presented, as well as the treatment scenarios that are applied to advanced-stage and recurrent disease. Drugs that have increased patient tolerance to these genotoxic regimens will also be discussed. Finally, the application of next-generation sequencing of tumor DNA or RNA to determine which of the more than 300 druggable mutations exist in these tumors will be discussed, primarily in the cancer recurrence setting. Prognostic tests based on RNA expression from tumors will be covered. Discussion of the rationale for insurance coverage of pharmacogenomics will also be covered and the impact of oncologic pharmacogenomics on future clinical trials will be examined. (48-0-3) PHRE 5516—Health Disparities in Chronic Diseases: The Role of the Pharmacist This course presents the main causes and pathways to health disparities in the United States. It focuses on chronic diseases, such as diabetes, cancer, and cardiovascular diseases. Emphasis is given to disparities associated with access to medication and pharmacy services and to adherence. Students learn about pharmacy-led interventions aimed at reducing health disparities. They are expected to use epidemiological data to study the disparities and to formulate recommendations to the pharmacy field. Students are assessed through hands-on structured assignments. (48-0-3) PHRE 5702—Introduction to Research Project In this course, M.S. students work under the supervision of one or more faculty members on a research project in pharmaceutical sciences. Students are involved in planning and executing an approved research project at the graduate level using basic techniques of scientific research. Students will be awarded three or four semester credits on the basis of 48 laboratory hours per credit hour. (0-[144–192]-[3–4]) PHRE 5999—Research in the Pharmaceutical Sciences In this course, students work under the direction/supervision of one or more facultymembers in a research laboratory. Students are involved in planning and executing an approved research project using basic techniques of scientific research. Students will be awarded 3 or 4 semester credits on the basis of 48 laboratory hours per credit. (0-[144–192]-[3–4])